Cytochrome P450 11B1 Inhibitors [MoA] - N0000193936
Pharmacologic Class Information
Pharmacologic Code | N0000193936 |
Pharmacologic Name | Cytochrome P450 11B1 Inhibitors |
Pharmacologic Uses |
|
Pharmacologic Concept | Mechanisms of Action - [MoA] |
Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Cytochrome P450 11B1 Inhibitors
The table contains 4 products whose active ingredient are classified under the same pharmacologic class Cytochrome P450 11B1 Inhibitors [MoA].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
55292-320 | Isturisa | Non-Proprietary Name: Osilodrostat | Tablet, Coated | Oral | Recordati Rare Diseases, Inc. | ACTIVE | |
55292-321 | Isturisa | Non-Proprietary Name: Osilodrostat | Tablet, Coated | Oral | Recordati Rare Diseases, Inc. | ACTIVE | |
55292-322 | Isturisa | Non-Proprietary Name: Osilodrostat | Tablet, Coated | Oral | Recordati Rare Diseases, Inc. | ACTIVE | |
72065-003 | Recorlev | Non-Proprietary Name: Levoketoconazole | Tablet | Oral | Xeris Pharmaceuticals, Inc. | ACTIVE |